Literature DB >> 9106385

Differentiation of epidermal growth factor-responsive neural precursor cells within neurospheres.

J Mokrý1, D Subrtová, S Nĕmecek.   

Abstract

Genetically unmodified neural precursor cells (NPCs) derived from rate embryonic cortex were stimulated with Long-epidermal growth factor in vitro to form multicellular neurospheres. In our study, histology and transmission electron microscopy was for the first time utilized for analysis of three-dimensional neurospheres. Immunohistochemical phenotypization carried out on paraffin-embedded section revealed that most cells in the neurosphere expressed high levels of vimentin that is normally found in immature neural cells. Majority of glial cells expressed glial fibrillary acidic protein (GFAP) that is a specific marker for differentiated astrocytes. On the other hand, myelin basic protein (MBP), a marker of oligodendrocytes, was found only in a discrete subpopulation of glial cells. Similarly, electron microscopy recognized only rate myelin sheaths surrounding axons. Some cells displayed neuron-like morphology and were labelled with antibodies recognizing the neuronal antigens: 210 kDa neurofilaments (NF 210) and microtubule associated protein-2 (MAP-2). Surprisingly well-developed interneuronal synapses were found electronmicroscopically. The presence of synaptic vesicles was also confirmed by immunohistochemical detection of synaptophysin. Our results show that NPCs in neurospheres gradually differentiate into glial and neuronal cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9106385

Source DB:  PubMed          Journal:  Acta Medica (Hradec Kralove)        ISSN: 1211-4286


  2 in total

1.  A novel method for culturing neural stem cells.

Authors:  Xue-Sheng Zheng; Xiao-Feng Yang; Wei-Guo Liu; Gang Shen; De-Sheng Pan; Ming Luo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-07-07       Impact factor: 2.416

2.  PPARgamma agonists inhibit growth and expansion of CD133+ brain tumour stem cells.

Authors:  W Chearwae; J J Bright
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.